Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance.

Smits RM, Veldhuijzen DS, van Middendorp H, Hissink Muller PCE, Armbrust W, Legger E, Wulffraat NM, Evers AWM.

Pediatr Rheumatol Online J. 2020 Feb 7;18(1):12. doi: 10.1186/s12969-020-0407-5.

2.

Pharmacological conditioning in the treatment of recent-onset rheumatoid arthritis: a randomized controlled trial study protocol.

Manaï M, van Middendorp H, Veldhuijzen DS, van der Pol JA, Huizinga TWJ, Evers AWM.

Trials. 2020 Jan 6;21(1):15. doi: 10.1186/s13063-019-3777-6.

3.

Placebo Effects in the Neuroendocrine System: Conditioning of the Oxytocin Responses.

Skvortsova A, Veldhuijzen DS, Pacheco-Lopez G, Bakermans-Kranenburg M, van IJzendoorn M, Smeets MAM, Wilderjans TF, Dahan A, van den Bergh O, Chavannes NH, van der Wee NJA, Grewen KM, van Middendorp H, Evers AWM.

Psychosom Med. 2020 Jan;82(1):47-56. doi: 10.1097/PSY.0000000000000759.

4.

How to prevent, minimize, or extinguish nocebo effects in pain: a narrative review on mechanisms, predictors, and interventions.

Manaï M, van Middendorp H, Veldhuijzen DS, Huizinga TWJ, Evers AWM.

Pain Rep. 2019 Jun 7;4(3):e699. doi: 10.1097/PR9.0000000000000699. eCollection 2019 May-Jun.

5.

Effects of Oxytocin on Placebo and Nocebo Effects in a Pain Conditioning Paradigm: A Randomized Controlled Trial.

Skvortsova A, Veldhuijzen DS, van Middendorp H, Colloca L, Evers AWM.

J Pain. 2019 Sep 5. pii: S1526-5900(19)30792-8. doi: 10.1016/j.jpain.2019.08.010. [Epub ahead of print]

6.

Antipruritic Placebo Effects by Conditioning H1-antihistamine.

Meeuwis SH, van Middendorp H, Pacheco-Lopez G, Ninaber MK, Lavrijsen APM, van der Wee N, Veldhuijzen DS, Evers AWM.

Psychosom Med. 2019 Nov/Dec;81(9):841-850. doi: 10.1097/PSY.0000000000000743.

7.

Effectiveness of Stress-Reducing Interventions on the Response to Challenges to the Immune System: A Meta-Analytic Review.

Schakel L, Veldhuijzen DS, Crompvoets PI, Bosch JA, Cohen S, van Middendorp H, Joosten SA, Ottenhoff THM, Visser LG, Evers AWM.

Psychother Psychosom. 2019;88(5):274-286. doi: 10.1159/000501645. Epub 2019 Aug 6. Review.

8.

Effects of Open- and Closed-Label Nocebo and Placebo Suggestions on Itch and Itch Expectations.

Meeuwis SH, van Middendorp H, van Laarhoven AIM, Veldhuijzen DS, Lavrijsen APM, Evers AWM.

Front Psychiatry. 2019 Jun 21;10:436. doi: 10.3389/fpsyt.2019.00436. eCollection 2019.

9.

How to best measure quality of life in coeliac disease? A validation and comparison of disease-specific and generic quality of life measures.

Burger JPW, van Middendorp H, Drenth JPH, Wahab PJ, Evers AWM.

Eur J Gastroenterol Hepatol. 2019 Aug;31(8):941-947. doi: 10.1097/MEG.0000000000001432.

PMID:
31045631
10.

Chronic pain following laparoscopic living-donor nephrectomy: Prevalence and impact on quality of life.

Bruintjes MHD, van Helden EV, de Vries M, Wirken L, Evers AWM, van Middendorp H, Kloke H, d'Ancona FCH, Langenhuijsen JF, Steegers MAH, Warlé MC.

Am J Transplant. 2019 Oct;19(10):2825-2832. doi: 10.1111/ajt.15350. Epub 2019 Apr 11.

11.

Economic evaluation of a tailored therapist-guided internet-based cognitive behavioural treatment for patients with psoriasis: a randomized controlled trial.

van Beugen S, Ferwerda M, van Middendorp H, Smit JV, Zeeuwen-Franssen MEJ, Kroft EBM, de Jong EMGJ, van de Kerkhof PCM, Kievit W, Evers AWM.

Br J Dermatol. 2019 Sep;181(3):614-616. doi: 10.1111/bjd.17848. Epub 2019 Jun 20. No abstract available.

PMID:
30822378
12.

Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis.

Berende A, Ter Hofstede HJM, Vos FJ, Vogelaar ML, van Middendorp H, Evers AWM, Kessels RPC, Kullberg BJ.

Neurology. 2019 Mar 26;92(13):e1447-e1455. doi: 10.1212/WNL.0000000000007186. Epub 2019 Feb 22.

13.

Conditioning cortisol in humans: design and pilot study of a randomized controlled trial.

Tekampe J, van Middendorp H, Sweep FCGJ, Roerink SHPP, Hermus ARMM, Evers AWM.

Pilot Feasibility Stud. 2019 Jan 18;5:9. doi: 10.1186/s40814-018-0382-5. eCollection 2019.

14.

Conditioned hormonal responses: A systematic review in animals and humans.

Skvortsova A, Veldhuijzen DS, Kloosterman IEM, Meijer OC, van Middendorp H, Pacheco-Lopez G, Evers AWM.

Front Neuroendocrinol. 2019 Jan;52:206-218. doi: 10.1016/j.yfrne.2018.12.005. Epub 2018 Dec 25.

PMID:
30590067
15.

Psychosocial consequences of living kidney donation: a prospective multicentre study on health-related quality of life, donor-recipient relationships and regret.

Wirken L, van Middendorp H, Hooghof CW, Sanders JF, Dam RE, van der Pant KAMI, Wierdsma JM, Wellink H, van Duijnhoven EM, Hoitsma AJ, Hilbrands LB, Evers AWM.

Nephrol Dial Transplant. 2019 Jun 1;34(6):1045-1055. doi: 10.1093/ndt/gfy307.

PMID:
30544241
16.

Tailored, Therapist-Guided Internet-Based Cognitive Behavioral Therapy Compared to Care as Usual for Patients With Rheumatoid Arthritis: Economic Evaluation of a Randomized Controlled Trial.

Ferwerda M, van Beugen S, van Middendorp H, Visser H, Vonkeman H, Creemers M, van Riel P, Kievit W, Evers A.

J Med Internet Res. 2018 Oct 11;20(10):e260. doi: 10.2196/jmir.9997.

17.

Occurrence, Chronicity and Intensity of Itch in a Clinical Consecutive Sample of Patients with Skin Diseases: A Multi-centre Study in 13 European Countries.

Schut C, Dalgard FJ, Halvorsen JA, Gieler U, Lien L, Aragones LT, Poot F, Jemec GBE, Misery L, Kemény L, Sampogna F, van Middendorp H, Balieva F, Linder D, Szepietowski JC, Lvov A, Marron SE, Altunay IK, Finlay AY, Salek S, Kupfer J.

Acta Derm Venereol. 2019 Feb 1;99(2):146-151. doi: 10.2340/00015555-3040.

18.

Illness perceptions and their association with 2 year functional status and change in patients with hand osteoarthritis.

Damman W, Liu R, Kaptein AA, Evers AWM, van Middendorp H, Rosendaal FR, Kloppenburg M.

Rheumatology (Oxford). 2018 Dec 1;57(12):2190-2199. doi: 10.1093/rheumatology/key231.

PMID:
30107461
19.

Role of personality traits in reporting the development of adverse drug reactions: a prospective cohort study of the Estonian general population.

Realo A, van Middendorp H, Kööts-Ausmees L, Allik J, Evers AWM.

BMJ Open. 2018 Jul 10;8(7):e022428. doi: 10.1136/bmjopen-2018-022428.

20.

Development and feasibility of a guided and tailored internet-based cognitive-behavioural intervention for kidney donors and kidney donor candidates.

Wirken L, van Middendorp H, Hooghof CW, Bremer TE, Hopman SPF, van der Pant KAMI, Hoitsma AJ, Hilbrands LB, Evers AWM.

BMJ Open. 2018 Jun 30;8(6):e020906. doi: 10.1136/bmjopen-2017-020906.

21.

Human Pharmacological Conditioning of the Immune and Endocrine System: Challenges and Opportunities.

Tekampe J, van Middendorp H, Sweep FCGJ, Roerink SHPP, Hermus ARMM, Evers AWM.

Int Rev Neurobiol. 2018;138:61-80. doi: 10.1016/bs.irn.2018.01.002. Epub 2018 Apr 2. Review.

PMID:
29681335
22.

Becoming an eCoach: Training therapists in online cognitive-behavioral therapy for chronic pain.

Terpstra JA, van der Vaart R, Spillekom-van Koulil S, van Dam A, Rosmalen JGM, Knoop H, van Middendorp H, Evers AWM.

Patient Educ Couns. 2018 Sep;101(9):1702-1707. doi: 10.1016/j.pec.2018.03.029. Epub 2018 Apr 7.

PMID:
29661704
23.

Enhancing Placebo Effects in Somatic Symptoms Through Oxytocin.

Skvortsova A, Veldhuijzen DS, Van Middendorp H, Van den Bergh O, Evers AWM.

Psychosom Med. 2018 May;80(4):353-360. doi: 10.1097/PSY.0000000000000571.

24.

Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease.

Berende A, Nieuwenhuis L, Ter Hofstede HJM, Vos FJ, Vogelaar ML, Tromp M, van Middendorp H, Donders ART, Evers AWM, Kullberg BJ, Adang EMM.

PLoS One. 2018 Apr 2;13(4):e0195260. doi: 10.1371/journal.pone.0195260. eCollection 2018.

25.

The Role of Therapy in Impairing Quality of Life in Dermatological Patients: A Multinational Study.

Balieva FN, Finlay AY, Kupfer J, Aragones LT, Lien L, Gieler U, Poot F, Jemec GBE, Misery L, Kemeny L, Sampogna F, van Middendorp H, Halvorsen JA, Ternowitz T, Szepietowski JC, Potekaev N, Marron SE, Altunay IK, Salek SS, Dalgard FJ.

Acta Derm Venereol. 2018 Jun 8;98(6):563-569. doi: 10.2340/00015555-2918.

26.

Applying the Common Sense Model to predicting quality of life in alopecia areata: The role of illness perceptions and coping strategies.

Willemse H, van der Doef M, van Middendorp H.

J Health Psychol. 2019 Sep;24(11):1461-1472. doi: 10.1177/1359105317752826. Epub 2018 Jan 22.

27.

Expectations about the effectiveness of pain- and itch-relieving medication administered via different routes.

Peerdeman KJ, Tekampe J, van Laarhoven AIM, van Middendorp H, Rippe RCA, Peters ML, Evers AWM.

Eur J Pain. 2018 Apr;22(4):774-783. doi: 10.1002/ejp.1163. Epub 2017 Dec 20.

28.

Placebo Effects of Open-label Verbal Suggestions on Itch.

Meeuwis SH, van Middendorp H, Veldhuijzen DS, van Laarhoven AIM, De Houwer J, Lavrijsen APM, Evers AWM.

Acta Derm Venereol. 2018 Feb 7;98(2):268-274. doi: 10.2340/00015555-2823. Erratum in: Acta Derm Venereol. 2019 Feb 28;99(3):357.

29.

Nail Involvement in Alopecia Areata: A Questionnaire-based Survey on Clinical Signs, Impact on Quality of Life and Review of the Literature.

Roest YBM, van Middendorp HT, Evers AWM, van de Kerkhof PCM, Pasch MC.

Acta Derm Venereol. 2018 Feb 7;98(2):212-217. doi: 10.2340/00015555-2810. Review.

30.

Tailored Therapist-guided Internet-based Cognitive-behavioural Treatment for Psoriasis and Rheumatoid Arthritis: Two Case Reports.

Koulil SS, Ferwerda M, van Beugen S, van Middendorp H, van de Kerkhof PCM, van Riel PLCM, Evers AWM.

Acta Derm Venereol. 2018 Feb 7;98(2):225-233. doi: 10.2340/00015555-2803.

31.

The effects of a psychological intervention directed at optimizing immune function: study protocol for a randomized controlled trial.

Schakel L, Veldhuijzen DS, van Middendorp H, Prins C, Joosten SA, Ottenhoff THM, Visser LG, Evers AWM.

Trials. 2017 May 26;18(1):243. doi: 10.1186/s13063-017-1983-7.

32.

Conditioning Immune and Endocrine Parameters in Humans: A Systematic Review.

Tekampe J, van Middendorp H, Meeuwis SH, van Leusden JW, Pacheco-López G, Hermus AR, Evers AW.

Psychother Psychosom. 2017;86(2):99-107. doi: 10.1159/000449470. Epub 2017 Feb 10. Review.

33.

Pre-donation cognitions of potential living organ donors: the development of the Donation Cognition Instrument in potential kidney donors.

Wirken L, van Middendorp H, Hooghof CW, Sanders JS, Dam RE, van der Pant KAMI, Berendsen ECM, Wellink H, Dackus HJA, Hoitsma AJ, Hilbrands LB, Evers AWM.

Nephrol Dial Transplant. 2017 Mar 1;32(3):573-580. doi: 10.1093/ndt/gfw421.

PMID:
28160472
34.

Attachment Styles of Dermatological Patients in Europe: A Multi-centre Study in 13 Countries.

Szabó C, Altmayer A, Lien L, Poot F, Gieler U, Tomas-Aragones L, Kupfer J, Jemec GBE, Misery L, Linder MD, Sampogna F, van Middendorp H, Halvorsen JA, Balieva F, Szepietowski JC, Romanov D, Marron SE, Altunay IK, Finlay AY, Salek SS, Dalgard F.

Acta Derm Venereol. 2017 Jul 6;97(7):813-818. doi: 10.2340/00015555-2619.

35.

A tailored-guided internet-based cognitive-behavioral intervention for patients with rheumatoid arthritis as an adjunct to standard rheumatological care: results of a randomized controlled trial.

Ferwerda M, van Beugen S, van Middendorp H, Spillekom-van Koulil S, Donders ART, Visser H, Taal E, Creemers MCW, van Riel PCLM, Evers AWM.

Pain. 2017 May;158(5):868-878. doi: 10.1097/j.pain.0000000000000845.

PMID:
28106666
36.

The burden of common skin diseases assessed with the EQ5D™: a European multicentre study in 13 countries.

Balieva F, Kupfer J, Lien L, Gieler U, Finlay AY, Tomás-Aragonés L, Poot F, Misery L, Sampogna F, van Middendorp H, Halvorsen JA, Szepietowski JC, Lvov A, Marrón SE, Salek MS, Dalgard FJ.

Br J Dermatol. 2017 May;176(5):1170-1178. doi: 10.1111/bjd.15280. Epub 2017 Apr 10.

PMID:
28032340
37.

Embracing Complexity beyond Systems Medicine: A New Approach to Chronic Immune Disorders.

Te Velde AA, Bezema T, van Kampen AH, Kraneveld AD, 't Hart BA, van Middendorp H, Hack EC, van Montfrans JM, Belzer C, Jans-Beken L, Pieters RH, Knipping K, Huber M, Boots AM, Garssen J, Radstake TR, Evers AW, Prakken BJ, Joosten I.

Front Immunol. 2016 Dec 12;7:587. doi: 10.3389/fimmu.2016.00587. eCollection 2016.

38.

The role of psychological factors in inflammatory rheumatic diseases: From burden to tailored treatment.

van Middendorp H, Evers AW.

Best Pract Res Clin Rheumatol. 2016 Oct;30(5):932-945. doi: 10.1016/j.berh.2016.10.012. Epub 2016 Nov 20. Review.

PMID:
27964797
39.

Tailored Therapist-Guided Internet-Based Cognitive Behavioral Treatment for Psoriasis: A Randomized Controlled Trial.

van Beugen S, Ferwerda M, Spillekom-van Koulil S, Smit JV, Zeeuwen-Franssen ME, Kroft EB, de Jong EM, Otero ME, Donders AR, van de Kerkhof PC, van Middendorp H, Evers AW.

Psychother Psychosom. 2016;85(5):297-307. doi: 10.1159/000447267. Epub 2016 Aug 11.

40.

Implicit stigmatization-related biases in individuals with skin conditions and their significant others.

van Beugen S, Maas J, van Laarhoven AI, Galesloot TE, Rinck M, Becker ES, van de Kerkhof PC, van Middendorp H, Evers AW.

Health Psychol. 2016 Aug;35(8):861-5. doi: 10.1037/hea0000404.

PMID:
27505208
41.

Predictors of perceived stigmatization in patients with psoriasis.

van Beugen S, van Middendorp H, Ferwerda M, Smit JV, Zeeuwen-Franssen ME, Kroft EB, de Jong EM, Donders AR, van de Kerkhof PC, Evers AW.

Br J Dermatol. 2017 Mar;176(3):687-694. doi: 10.1111/bjd.14875. Epub 2016 Dec 22.

PMID:
27436615
42.

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.

Berende A, ter Hofstede HJ, Vos FJ, van Middendorp H, Vogelaar ML, Tromp M, van den Hoogen FH, Donders AR, Evers AW, Kullberg BJ.

N Engl J Med. 2016 Mar 31;374(13):1209-20. doi: 10.1056/NEJMoa1505425.

43.

Prevalence and relevance of Type D personality in fibromyalgia.

van Middendorp H, Kool MB, van Beugen S, Denollet J, Lumley MA, Geenen R.

Gen Hosp Psychiatry. 2016 Mar-Apr;39:66-72. doi: 10.1016/j.genhosppsych.2015.11.006. Epub 2015 Dec 2.

PMID:
26804772
44.

Measuring the Therapeutic Relationship in Internet-Based Interventions.

Ferwerda M, van Beugen S, van Riel PC, van de Kerkhof PC, de Jong EM, Smit JV, Zeeuwen-Franssen ME, Kroft EB, Visser H, Vonkeman HE, Creemers MC, van Middendorp H, Evers AW.

Psychother Psychosom. 2016;85(1):47-9. doi: 10.1159/000435958. Epub 2015 Nov 27. No abstract available.

PMID:
26610272
45.

The Course and Predictors of Health-Related Quality of Life in Living Kidney Donors: A Systematic Review and Meta-Analysis.

Wirken L, van Middendorp H, Hooghof CW, Rovers MM, Hoitsma AJ, Hilbrands LB, Evers AW.

Am J Transplant. 2015 Dec;15(12):3041-54. doi: 10.1111/ajt.13453. Epub 2015 Sep 28. Review.

46.

The role of outcome expectancies for a training program consisting of meditation, breathing exercises, and cold exposure on the response to endotoxin administration: a proof-of-principle study.

van Middendorp H, Kox M, Pickkers P, Evers AW.

Clin Rheumatol. 2016 Apr;35(4):1081-5. doi: 10.1007/s10067-015-3009-8. Epub 2015 Jul 21.

47.

ARE INTRAVITREAL INJECTIONS WITH ULTRATHIN 33-G NEEDLES LESS PAINFUL THAN THE COMMONLY USED 30-G NEEDLES?

van Asten F, van Middendorp H, Verkerk S, Breukink MB, Lomme RM, Hoyng CB, Evers AW, Klevering BJ.

Retina. 2015 Sep;35(9):1778-85. doi: 10.1097/IAE.0000000000000550.

PMID:
25901838
48.

Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis.

Berende A, ter Hofstede HJ, Donders AR, van Middendorp H, Kessels RP, Adang EM, Vos FJ, Evers AW, Kullberg BJ.

BMC Infect Dis. 2014 Oct 16;14:543. doi: 10.1186/s12879-014-0543-y.

49.

Body attention, ignorance and awareness scale: assessing relevant concepts for physical and psychological functioning in psoriasis.

van Beugen S, Ograczyk A, Ferwerda M, Smit JV, Zeeuwen-Franssen ME, Kroft EB, de Jong EM, Zalewska-Janowska A, Donders AR, van de Kerkhof PC, van Middendorp H, Evers AW.

Acta Derm Venereol. 2015 Apr;95(4):444-50. doi: 10.2340/00015555-1977.

50.

Immune responses to stress in rheumatoid arthritis and psoriasis.

de Brouwer SJ, van Middendorp H, Stormink C, Kraaimaat FW, Joosten I, Radstake TR, de Jong EM, Schalkwijk J, Donders AR, Eijsbouts A, van de Kerkhof PC, van Riel PL, Evers AW.

Rheumatology (Oxford). 2014 Oct;53(10):1844-8. doi: 10.1093/rheumatology/keu221. Epub 2014 May 20.

PMID:
24850878

Supplemental Content

Loading ...
Support Center